News

The agreement grants Hamilton Thorne (HT) the exclusive rights to sell the confocal product to the regenerative medical research market that Hamilton Thorne serves worldwide. Current methods of

According to a new development and licensing agreement, RaySearch will develop software modules for Model-Based Segmentation (MBS) and treatment planning of Volumetric Modulated Arc Therapy (VMAT) for Oncentra

Dr Hixson currently serves as chairman of the board of Sequenom, a genetics and molecular diagnostic company. Dr Hixson is also a member of the board of Infinity

As part of the restructuring, Metabasis will focus on the company’s product candidates, MB07811 for the treatment of hyperlipidemia and MB07803 for the treatment of type 2 diabetes,

Mr Bennett has held senior executive positions with several companies in the orthopedic and spine industry including: executive vice president, officer, and board member of NuVasive; early investor,

Financial results for the fourth quarter ended Dec. 31, 2008. Diluted earnings per share, excluding specified items, were $1.06, reflecting 14.0% growth, in line with Abbott’s previous forecast.

This new round of financing was completed through TaiGen Biopharmaceuticals Holdings Limited (Cayman), the parent company of TaiGen Biotechnology. The proceeds are to be used primarily for advancing

Mr Bryant will begin employment with Quidel and join the Quidel board on February 2, 2009. Caren Mason will continue in her current capacity as president and CEO

Scott Gottlieb served as FDA Deputy Commissioner for Medical and Scientific Affairs for the period 2005-2007, and prior to that, from 2003-2004, as senior advisor for medical technology